These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27447567)

  • 1. Controlled release strategy of paclitaxel by conjugating to matrix metalloproteinases-2 sensitive peptide.
    Huang C; Yi X; Kong D; Chen L; Min G
    Oncotarget; 2016 Aug; 7(32):52230-52238. PubMed ID: 27447567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery.
    Yamada R; Kostova MB; Anchoori RK; Xu S; Neamati N; Khan SR
    Cancer Biol Ther; 2010 Feb; 9(3):192-203. PubMed ID: 20023432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent tumor targeting drug release system comprising MMP-2 specific peptide fragment with self-assembling characteristics.
    Hua D; Kong W; Zheng X; Zhou Z; Yu B; Li Y; Wang Y; Yang X; Liu C; Tang L; Li Y; Gong M
    Drug Des Devel Ther; 2014; 8():1839-49. PubMed ID: 25342883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
    Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
    Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
    Lv S; Tang Z; Zhang D; Song W; Li M; Lin J; Liu H; Chen X
    J Control Release; 2014 Nov; 194():220-7. PubMed ID: 25220162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes.
    Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J
    J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
    Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug.
    Jang MK; Jeong YI; Nah JW
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
    Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor efficacy by cyclic RGDyK-conjugated and paclitaxel-loaded pH-responsive polymeric micelles.
    Gao Y; Zhou Y; Zhao L; Zhang C; Li Y; Li J; Li X; Liu Y
    Acta Biomater; 2015 Sep; 23():127-135. PubMed ID: 26013038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
    Hu H; Lin Z; He B; Dai W; Wang X; Wang J; Zhang X; Zhang H; Zhang Q
    J Control Release; 2015 Dec; 220(Pt A):189-200. PubMed ID: 26474677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic study of the covalent loading of paclitaxel via disulfide linkers for controlled drug release.
    Yuan L; Chen W; Hu J; Zhang JZ; Yang D
    Langmuir; 2013 Jan; 29(2):734-43. PubMed ID: 23252889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The promise of paclitaxel-peptide conjugates for MMP-2-targeted drug delivery.
    Huang Y; Shi J; He Q; Sheikh MS
    Cancer Biol Ther; 2010 Feb; 9(3):204-5. PubMed ID: 20118656
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
    Springate CM; Jackson JK; Gleave ME; Burt HM
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):239-47. PubMed ID: 15864591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of paclitaxel-BGL conjugates.
    Nemoto H; Katagiri A; Kamiya M; Kawamura T; Matsushita T; Matsumura K; Itou T; Hattori H; Tamaki M; Ishizawa K; Miyamoto L; Abe S; Tsuchiya K
    Bioorg Med Chem; 2012 Sep; 20(18):5559-67. PubMed ID: 22892212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral delivery of paclitaxel using a thermosensitive hydrogel in human tumor xenografts.
    Kim JH; Lee JH; Kim KS; Na K; Song SC; Lee J; Kuh HJ
    Arch Pharm Res; 2013 Jan; 36(1):94-101. PubMed ID: 23371803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
    Wang G; Yu B; Wu Y; Huang B; Yuan Y; Liu CS
    Int J Pharm; 2013 Mar; 446(1-2):24-33. PubMed ID: 23402977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and in vitro cytotoxicity studies of a macromolecular conjugate of paclitaxel bearing oxytocin as targeting moiety.
    Cavallaro G; Maniscalco L; Campisi M; Schillaci D; Giammona G
    Eur J Pharm Biopharm; 2007 May; 66(2):182-92. PubMed ID: 17182230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer.
    Yin T; Wang L; Yin L; Zhou J; Huo M
    Biomaterials; 2015 Aug; 61():10-25. PubMed ID: 25996409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.